References
- Mercer DW. A historical background in cardiac markers. Med Lab Observer 1996; 28(7):45–51
- Vaidya HC, Maynard Y, Dietzler DN, et al. Direct measurement of creatine kinase-MB activity in serum after extraction with a monoclonal antibody specific to the MB isoenzyme. Clin Chem 1986; 32(4):657–63
- Kagen L, Scheidt S, Butt A. Serum myoglobin in myocardial infarction: the “staccato phenomenon.” Is acute myocardial infarction in man an intermittent event? Am J Med 1977; 62(l):86–92
- Puleo PR, Meyer D, Wathen C, et al. Use of a rapid assay of sub- forms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994; 331(9):561–6
- Wu AH, Wang XM, Gornet TG, et al. Creatine kinase MB isoforms in patients with skeletal muscle injury: ramifications for early detection of acute myocardial infarction. Clin Chem 1992; 38(12): 2396–400
- Katus HA, Scheffold T, Remppis A, et al. Proteins of the troponin complex. Lab Med 1992; 23(5):311–7
- Ohman EM, Armstrong PW, Christenson RH, et al, for the GUSTO Ila Investigators. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996; 335(18):1333–41
- Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac- specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335(18): 1342–9
- Wu AH, Valdes R Jr, Apple FS, et al. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. Clin Chem 1994; 40(6):900–7
- Wu AH, Clive JM. Impact of CK-MB testing policies on hospital length of stay and laboratory costs for patients with myocardial infarction or chest pain. Clin Chem 1997; 43(2):326–32